World / Health & Beauty
Alkermes Presents Positive Preclinical Data On Naltrexone For Extended-Release Injectable Suspension At Annual Meeting Of Controlled Release Society
16.07.2008 08:15
medicalnewstoday.com
Alkermes, Inc. (NASDAQ: ALKS) announced positive preclinical results which demonstrated naltrexone for extended-release injectable suspension (XR-NTX) was more effective in an animal model of substance abuse compared to oral naltrexone therapy. The data were presented in an oral session at the 35th Annual Meeting and Exposition of the Controlled Release Society in New York City.
World
Neurology
Full-Day Kindergarteners' Reading, Math Gains Fade By 3rd Grade
16.07.2008 08:15
medicalnewstoday.com
Children in full-day kindergarten have slightly better reading and math skills than children in part-day kindergarten, but these initial academic benefits diminish soon after the children leave kindergarten. This loss is due, in part, to issues related to poverty and the quality of children's home environments. Those are the findings from a new study by researchers at the University of Pittsburgh and Loyola University Chicago.
World
Neurology
Scientists Identify A New Molecular Brake That Can Curb Excessive Immune Activation
16.07.2008 08:15
medicalnewstoday.com
In new research published in the open access, peer-reviewed online journal PLoS ONE, a team of scientists from NYU School of Medicine report the identification of a molecule expressed on a special class of T cells called regulatory T cells that appears to play a role in allowing these cells to control immune responses.
World
Immunology
FDA Approves Energex Systems, Inc. Non-Drug Therapy For HIV Research
16.07.2008 08:15
medicalnewstoday.com
Energex Systems, Inc. announced that it has been granted approval from the Federal Food and Drug Administration (FDA) to utilize its experimental HemoModulation™ therapy in a clinical trial of HIV infected patients. The purpose of the study will be to demonstrate safety and monitor viral load changes in patients who are not yet eligible for antiviral drug therapy. HIV is a retrovirus that attacks the immune system, destroying or impairing its function.
World
HIV/AIDS
NanoViricide's EKC Eye Drug Candidate Stopped Clinical Conjunctivitis Pathology
16.07.2008 08:15
medicalnewstoday.com
NanoViricides, Inc. (OTC BB: NNVC.OB) reported that excellent efficacy of its EKC-Cide™ nanoviricide drug candidate was revealed upon statistical analyses of clinical scores from the first animal study.
World
Eyesight Disorders
Paradigm Medical Industries Records Initial Sales Of Early Glaucoma Detection Device
16.07.2008 08:15
medicalnewstoday.com
Paradigm Medical Industries, Inc. (OTCBB: PMED) has begun selling the Glaid-PERG electrophysiology instrument for the early detection of glaucoma. Pricing and volumes were not disclosed. "We've recorded sales in select U.S. cities of this revolutionary FDA-approved device, following its introduction at the American Society for Cataract Refractive Surgeons (ASCRS) in April," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax.
World
Eyesight Disorders
New Publication Shows Cleviprex™ Is Effective For Rapid Treatment Of Acute Hypertension After Cardiac Surgery
16.07.2008 08:15
medicalnewstoday.com
The Medicines Company (NASDAQ: MDCO) announced that the results of ESCAPE -2, a pivotal Phase 3 efficacy trial of its investigational agent Cleviprex™ (clevidipine butyrate) injectable emulsion, were published in the July issue of the journal Anesthesia and Analgesia. The clinical trial demonstrated that Cleviprex is effective and safe in the rapid treatment of acute hypertension after cardiac surgery.
World
Cardiology
Abraxis BioScience Announces Approval To Market ABRAXANE For Metastatic Breast Cancer In China
16.07.2008 08:15
medicalnewstoday.com
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced it has received approval from the China State Food and Drug Administration to market ABRAXANE® Paclitaxel for Injection (Albumin Bound) for the treatment of breast cancer after failure of standard chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. The Phase III clinical trials in the U.S.
World
Cancer
Breast Cancer Patients Benefit From The Improved Support Supplied By Focused Internet Services
16.07.2008 08:15
medicalnewstoday.com
A new study in the Journal of Communication reveals that access to an integrated system of internet health resources helps patients more than simply providing a list of URLs to accredited sites. Breast cancer affects one in eight women and is the second leading cause of cancer death among women. Led by David H.
World
Cancer
Astrazeneca Sponsors Service User- Involvement In Research Into Recovery For Mental Health
16.07.2008 07:12
medicalnewstoday.com
Two leading mental health charities, Rethink and MDF The BiPolar Organisation today announced the start of a new partnership with and project sponsored by AstraZeneca. It comprises of experiential research to identify what hinders and helps achieve recovery and aims to help to put recovery at the heart of mental health reform. It will report late 2008.
World
Mental Disorders
Easing The Pain Of Diabetes - Dying A Depression Drug For Common Nerve Condition
16.07.2008 07:12
medicalnewstoday.com
To ease pain and numbness associated with diabetes, NewYork-Presbyterian/Weill Cornell physician-scientists are studying a drug previously used for depression to treat peripheral neuropathy. Diabetics often suffer from this condition because of high blood sugar levels that damage nerve cells. Those with peripheral neuropathy often endure chronic pain, cramping and sleepless nights that prevent them from living a normal lifestyle.
World
Depression
Ron Greenspan DDS Creates Plan To Eliminate The Barriers To Orthodontic Treatment
16.07.2008 07:12
medicalnewstoday.com
Straight teeth can improve your dental health, enhance your facial appearance and even build your self esteem. In short, a beautiful smile can make a huge difference in the quality of one's life. Both children and adults can benefit from the confidence boost a remarkable smile can bring. Orthodontic treatment can benefit social and career success as well as improve a person's general attitude toward life.
World
Dentistry
Therapeutic Lifestyle Change (TLC) Programs: The Key To Fighting Chronic Disease
16.07.2008 07:12
medicalnewstoday.com
Chronic diseases such as type 2 diabetes and heart disease have reached epidemic proportions, affecting half of Americans and costing $1.5 trillion annually. But a little-known and relatively inexpensive tool called a TLC program has been shown to be effective in preventing, managing, or even reversing, many of our most prevalent chronic conditions. So why don't more health professionals offer TLC? How TLC Programs Work
World
Alternative Medicine
Stem Cell Researchers At UM Enrolling Patients In Heart Failure Study - Catheter Injection System To Be Used
16.07.2008 07:11
medicalnewstoday.com
Stem cell researchers at the University of Miami Miller School of Medicine are ready to enroll patients in another breakthrough study aimed at treating heart failure. They have received approval from the Food and Drug Administration for a study using a Helical Infusion catheter system to inject stem cells into the heart.
World
Cardiology
Further Evidence For Genetic Contribution To Autism Discovered By Caltech And UNC Research
16.07.2008 07:11
medicalnewstoday.com
Some parents of children with autism evaluate facial expressions differently than the rest of us--and in a way that is strikingly similar to autistic patients themselves, according to new research by neuroscientist Ralph Adolphs of the California Institute of Technology and psychiatrist Joe Piven at the University of North Carolina at Chapel Hill.
World
Autism
English